These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 15387353)
1. Pharmacodynamics and pharmacokinetics of oral contraceptives co-administered with alosetron (Lotronex). Koch K; Campanella C; Baidoo CA; Manzo JA; Ameen VZ; Kersey KE Dig Dis Sci; 2004 Aug; 49(7-8):1244-9. PubMed ID: 15387353 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol. Carlström K; Lunell NO; Zador G Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992 [TBL] [Abstract][Full Text] [Related]
3. Lansoprazole does not affect the bioavailability of oral contraceptives. Fuchs W; Sennewald R; Klotz U Br J Clin Pharmacol; 1994 Oct; 38(4):376-80. PubMed ID: 7833230 [TBL] [Abstract][Full Text] [Related]
4. Effect of oral siponimod (BAF312) on the pharmacokinetics and pharmacodynamics of a monophasic oral contraceptive in healthy female subjects. Biswal S; Veldandi UK; Derne C; Golla G; Muhsen N; Legangneux E Int J Clin Pharmacol Ther; 2014 Nov; 52(11):996-1004. PubMed ID: 25161159 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel. Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174 [TBL] [Abstract][Full Text] [Related]
6. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women. Griffith SG; Dai Y Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769 [TBL] [Abstract][Full Text] [Related]
7. Assessment of disease-drug-drug interaction between single-dose tocilizumab and oral contraceptives in women with active rheumatoid arthritis. Zhang X; Rowell L; Fettner S; Lau C; Teuber D Int J Clin Pharmacol Ther; 2014 Jan; 52(1):27-38. PubMed ID: 24161161 [TBL] [Abstract][Full Text] [Related]
8. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive. Coates PE; Mesure R Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095 [TBL] [Abstract][Full Text] [Related]
9. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study. Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593 [TBL] [Abstract][Full Text] [Related]
10. No clinically relevant drug-drug interactions when dalcetrapib is co-administered with a monophasic oral contraceptive (Microgynon® 30). Young A; Anzures-Cabrera J; Derks M Int J Clin Pharmacol Ther; 2012 Apr; 50(4):248-56. PubMed ID: 22456295 [TBL] [Abstract][Full Text] [Related]
11. Effect of brivaracetam (400 mg/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women. Stockis A; Rolan P J Clin Pharmacol; 2013 Dec; 53(12):1313-21. PubMed ID: 24386664 [TBL] [Abstract][Full Text] [Related]
12. Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women. Trezza C; Ford SL; Gould E; Lou Y; Huang C; Ritter JM; Buchanan AM; Spreen W; Patel P Br J Clin Pharmacol; 2017 Jul; 83(7):1499-1505. PubMed ID: 28087972 [TBL] [Abstract][Full Text] [Related]
13. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
14. Laboratory criteria for menopause in women using oral contraceptives. Creinin MD Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618 [TBL] [Abstract][Full Text] [Related]
15. Pulsatile luteinizing hormone patterns in long term oral contraceptive users. Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046 [TBL] [Abstract][Full Text] [Related]
16. The effects of ampicillin on oral contraceptive steroids in women. Back DJ; Breckenridge AM; MacIver M; Orme M; Rowe PH; Staiger C; Thomas E; Tjia J Br J Clin Pharmacol; 1982 Jul; 14(1):43-8. PubMed ID: 6809025 [TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers. Cawello W; Rosenkranz B; Schmid B; Wierich W Epilepsia; 2013 Mar; 54(3):530-6. PubMed ID: 23360419 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of ethinylestradiol in blood and endometrium of women taking oral contraceptives: the sequential therapy. Cortés-Gallegos V; Carranco A; Sojo I; Navarrette M; Cervantes C; Parra A Fertil Steril; 1979 Nov; 32(5):524-7. PubMed ID: 499582 [TBL] [Abstract][Full Text] [Related]
19. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781 [TBL] [Abstract][Full Text] [Related]
20. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]